Skip to main content

Animal organs for human transplantation: how close are we ?

You know  about xenotransplantation


Solid organ transplantation ,by most measure a phenomenal success. One potential  solution to organ availability  crises is the use of animal as organ donar for humans ( xenotransplantation).

Organ transplantation has been one of the success  stories of the latter part of 20th century, this field now solidly entrenched in modern medical therapy. Since last decades, thousands of the patients received new kidneys, livers, heart and other organs( lung, pancreas, and intestine ) routinely transplanted, clinical results of these interventions have meant the restoration of meaningful, protective and active lives to recipients of all organs.

Vexingly, the transplant community has not been able to meet the demand for donar organ, to reduced the overcome finding  a alternative, more plenityful  supply of replacement organs for human transplantation.

THE IDEAL DONOR ANIMAL

   A long list emerging when we considered  the preferred characteristics  of animals to be appropriate to be organ donar for humans
 ●Animal  should be of compatible anatomy  and physiology for intended organ to function well
 ● No possibility  to cross species ( animal to human) infection  should exsist (especially  virus)
Non human primates (apes and monkeys) most like human anatomically and physiologically, but they may possibly resistance to human  diseases ( HIV and hepatitis B), some monkey viruses ( herpes 8) deadly  to human in a matter of days. Finally, ethical obstacle to using non human  primate as a donors  for human.

The pig with large litter ( up to 10 littermate), short gasteration time ( 4 minths) anatomically and physiologically  similar to humans and long history  of providing medicinals ( skin, insulin, cardiac prosthesis, cardiac factor for humans has become  the most likely  condidate for consideration  as an organ donor.

IMMUNOLOGICAL BARRIERS AND PRECLINICAL RESULTS

 The use of pig organ as xenografts came one step closer to reality with discovery  in  human of naturally occurring antibody  cross - reacting with porcine cell( especially  vascular endothelium cells).
 These xenoreactive antibodies(IgM & IgGs) may exist as the result of cross reactivity with enteric  bacteria, and are found in human. They bind in pig with Alfa 1,3- galactose carbohydrates  unit, which morphological similar with ABO blood group antigen , This antigen is very high in noumber in porcine vascular  endothelial cell.
Unmodulated, prompt antigen antibody reaction, complement activation, endothelial cell permeability, capillary  fibrin deposition  with ischemia, hence hyperacute rejection.

A noumber of approaches have been proposed to reduced or eliminate this antigen- antibody interaction, These include antibody absorption  through
Pretransplant organs( liver or lung ) or immunoaffanity  column perfussion, the continious infusion of  antibody depleting carbohydrates, the modification  of animal lacking ( or with greatly reduced ) alfa 1,3- Gal antigens and accomodation.

THESE STRATAGIES ARE IN VARIOUS STAGE OF DEVELOPMENT.  

Comments

Popular posts from this blog

What is hunta virus and it's consequences

HOW IT INFECT THE HUMAN                  Single standed ,enveloped, negative sense, RNA virus which normally  infect rodents where they don't cause disease (work as reserviour) SPREAD -   Hunta virus present in the urin and feaces  of rodents , spread of infection when the people are contact with rodents or their dropping or urins or possibly  to inhale virus from droppings. Very rear possibilities to person to person infection. ON THE BASIS OF DIFFERENT  TYPES OF STRAINS, VIRUS  AFFECTS  DIFFERENT  ORGANS; In lunga, causing hunta virus pulmonary  syndrome (HPS) In kidney, causing  hemorrahagic fever with renal syndrome (HFRS) However many symptoms of two infection are overlaps  in initial.  HUNTA VIRUS PULMONARY  SYNDROME People with HPS then develope  a cough and shortness of breath, which may become serious , fluid  collects around  the neck and low pressure Death in up to about 50% of the people . Those who servive first few day then recovery is about 2-

Modern medical therapy over mesenchymal stem cells in 2018

why modern medical therapy  work on mesenchymal  stem cells (MSCs) Mesenchymal  stem cell are self- renewing, multipotent, progenitor  cell with multilineage potential to differentiate into cell type of mesodermal  origin. SUCH AS - adipocytes, osteocytes and condrocytes,  while MSCs  are most commonly  isolated from bone marrow  by aspiration process, they are also from other tissue including adipose tissue, placenta, amniotic fluid & umbilical card blood. Main resion - due to their accessibility & convenient  protocols, MSCs have been recognised  as promising  for  cellular therapy, regenerative medicines, and tissue  engineering . IN CELLULAR  THERAPY- This processes take 2-3 weeks. This kind of mature  , fully differentiate  cell  phenotype and the noumber  of the cells though this can be influenced in 3 ways. Firstly by varying in initial seed density  in the culture media Secound through changing  the conditions of the medium during  expansion Third &